Aegis Vopak Terminals Ltd
AEGISVOPAKAegis Vopak Terminals Ltd's earnings have outrun its stock. EPS grew +37.9% in a year against a +19.4% price move.
Biggest watch item: the P/E sits at the 69th percentile of its own range — the multiple has already done part of the work.
The price is in a confirmed uptrend (9 weeks in) while the P/E sits at the 69th percentile of its own 1-year range. Underneath, the last four quarters read improving — profit −12.7% year on year, and 247% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Aegis Vopak Terminals Ltd trades at ₹295, in a confirmed uptrend and 9 weeks into that stage. That is +20.2% against its own 200-day average. It sits at 100% of a 52-week range of ₹172 to ₹295. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 17 straight weeks.
Today the stock is in a confirmed uptrend — week 9 of stage 2, confirmed. At ₹295 it trades +20.2% versus its 200-day average and sits at 100% of its 52-week range (₹172–₹295).
Against the market, two honest reads. Cumulative: over the last 1.3 years the stock moved +15% while the NIFTY 500 moved −2% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 17 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Story check
Aegis Vopak Terminals Ltd's story is not scored yet against the markers our research file set on 19 July 2026. Where it sits in its own cycle: Not stated in the research file. Our fortnightly research layers last read it on 19 July 2026.
Our read, 19 July 2026. A high-margin terminal operator with cash conversion and material capacity catalysts, but a demanding valuation and documented commissioning slippage make execution timing the binding risk.
What is proven. A high-margin terminal operator with cash conversion and material capacity catalysts, but a demanding valuation and documented commissioning slippage make execution timing the binding risk.
What is not proven yet. Confidence increases with on-time commissioning, reported throughput conversion and operating cash flow that remains ahead of PAT. The thesis breaks if the largest capacity projects slip again, realization ramps slowly, or interest cost rises with new debt before the assets earn.
🚨 What would change our mind. Confidence increases with on-time commissioning, reported throughput conversion and operating cash flow that remains ahead of PAT. The thesis breaks if the largest capacity projects slip again, realization ramps slowly, or interest cost rises with new debt before the assets earn.
Layer 1 read, 19 July 2026 — KEEP. The core business is genuinely expanding and self-funding — revenue rose to Rs 243cr at a 74% margin and 3-year operating cash is 2.47x profit. But the valuation demands 44.7% growth the model calls IMPOSSIBLE, and the two capacity projects meant to deliver that growth (the Kandla-Gorakhpur pipeline, South India expansion) have both been pushed out.
What would change Layer 1’s mind. On-time commissioning of JNPT/Kandla-Gorakhpur with reported throughput conversion and OCF staying ahead of PAT would raise conviction; a further slip on the largest projects or interest cost rising with new debt before assets earn breaks it.
Layer 2 read, 19 July 2026 — BENCH. The engine is genuine — Rs 243cr revenue at a 74% operating margin with 3-year OCF/PAT of 2.47 — and its OWN operating cycle is at trough (recovering), which is why the top-decile PE partly reflects a depressed early-life denominator rather than pure over-valuation. But it carries TWO EXTREME critical signals (MoS -76.8%, PE 96.8) and, decisively, the two catalysts the thesis is bridged on have already slipped: the Kandla-Gorakhpur pipeline pushed to H1 FY27 and South India timelines withdrawn, while its own FCF swung to -Rs 2,375cr on a capex surge. There is no stock-specific external DROP-grade negative — the 'Miscellaneous' sector is a statistical residual (AVOID-as-a-sector, single…
What would change Layer 2’s mind. On-time commissioning of Kandla-Gorakhpur (H1 FY27) or JNPT WITH reported throughput conversion and OCF staying ahead of PAT would flip BENCH->ADVANCE; conversely a THIRD milestone slip, or interest cost rising faster than operating profit as new debt funds the capex, would flip BENCH->DROP (thesis' own would_change_my_mind + interest-leverage driver stops_working_if).
The test written in advance. Confidence increases with on-time commissioning, reported throughput conversion and operating cash flow that remains ahead of PAT. The thesis breaks if the largest capacity projects slip again, realization ramps slowly, or interest cost rises with new debt before the assets earn. — the thesis as written as stated by the next result.
The test written in advance. Execution timeline risk — Execution timeline risk A further revision to JNPT, the Kandla-Gorakhpur pipeline or ammonia commissioning timetable. by the next result.
The test written in advance. High valuation with limited history — High valuation with limited history Earnings delivery falls short while valuation stays elevated. by the next result.
What the company does. Operating profit and cash flow are strong, while lower interest cost has amplified PAT since listing. JNPT, the Kandla-Gorakhpur pipeline and Pipavav ammonia are identifiable throughput and realization catalysts. Valuation is high even after normalization, and the short history limits confidence in any through-cycle multiple conclusion.
| Dial | Now | Was | Why it matters | Watch line |
|---|---|---|---|---|
| JNPT liquid capacity ramp | in play | — | New JNPT capacity can add high-margin terminal earnings if commissioning and realization match management's demand view. | Commissioning slips again or reported realization does not support the expected demand advantage. |
| Pipeline-enabled gas throughput | in play | — | The Kandla-Gorakhpur link can improve evacuation and throughput at key gas hubs. | The connection slips or throughput does not improve after commissioning. |
| Pipavav ammonia platform | in play | — | A long-term offtake agreement can create a new terminaling vertical, subject to customer-plant commissioning. | The customer plant or terminal commissioning slips, delaying take-or-pay revenue. |
| Interest and operating leverage | in play | — | Lower interest cost and new capacity can translate operating growth into faster PAT growth. | Interest expense rises faster than operating profit as new debt funds projects. |
🚨 What the surface reading misses. The surface reading is: PAT grew faster than operating earnings. The research reads it further: New capacity is the operating co-mover and lower interest cost is the financial co-mover. Both must persist for PAT growth to remain more than a one-period base effect.
🚨 What the surface reading misses. The surface reading is: Interest cost fell after the IPO period before rising in the latest quarter. The research reads it further: Management explicitly says IPO proceeds repaid borrowings and the early decline corroborates that mechanism. The March increase is a warning that the next capex cycle can add funding cost.
Lever 2 · Value-added mix — BUILDING. New JNPT capacity can add high-margin terminal earnings if commissioning and realization match management's demand view. What proves it keeps working: JNPT liquid capacity ramp. It stops working if Commissioning slips again or reported realization does not support the expected demand advantage.
Lever 12 · New product launch — BUILDING. The Kandla-Gorakhpur link can improve evacuation and throughput at key gas hubs. What proves it keeps working: Pipeline-enabled gas throughput. It stops working if The connection slips or throughput does not improve after commissioning.
Lever 1 · Operating leverage — BUILDING. Lower interest cost and new capacity can translate operating growth into faster PAT growth. What proves it keeps working: Interest and operating leverage. It stops working if Interest expense rises faster than operating profit as new debt funds projects.
Sources: our stock research file (19 July 2026) · quarterly results through Jun 26 · the company’s own earnings calls. The story check is re-scored every results season; the record below never changes.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Aegis Vopak Terminals Ltd reported ₹234 Cr of revenue in the Jun 26 quarter, +12.5% year on year. That is the 5th straight quarter of year-on-year growth. The last full year, FY26, came in at ₹923 Cr. The last four reported quarters add to ₹904 Cr.
FY26 revenue came in at ₹923 Cr (+17.0% on the year). The latest quarter (Jun 26) printed ₹234 Cr, +12.5% year on year — the 5th consecutive quarter of year-over-year growth.
FY26-Q4. revenue ₹243 Cr and profit ₹74 Cr as reported.
FY27-Q1. revenue ₹234 Cr and profit ₹69 Cr as reported.
Why-sources: our stock research file (19 July 2026) and the company’s own results for those quarters.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Aegis Vopak Terminals Ltd's operating margin is 77.0% in the Jun 26 quarter, +2.0 percentage points against the same quarter a year ago. Across 4 fiscal years the operating margin has ranged 65.0% to 74.0%. The current quarter is running above every full year in that window.
Why this happened. JNPT has a defined capacity programme and management expects strong realization from commissioning. West Coast demand is the qualitative corroboration; reported utilization and tariff are the economic proof.
The latest quarter's operating margin is 77.0%, +2.0 pp against the same quarter a year ago. Across 4 fiscal years the operating margin has ranged 65.0%–74.0%.
Why the margin moved: operating margin went +2.1 pp year on year while gross margin went +0.0 pp — the gain came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
FY26-Q4. revenue ₹243 Cr and profit ₹74 Cr as reported.
FY27-Q1. revenue ₹234 Cr and profit ₹69 Cr as reported.
Why-sources: our stock research file (19 July 2026) and the company’s own results for those quarters.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Aegis Vopak Terminals Ltd earned ₹69.0 Cr of net profit in the Jun 26 quarter, −12.7% year on year. Full-year FY26 profit was ₹342 Cr. That is 29.5% of the quarter's revenue. The same quarter a year earlier earned ₹79.0 Cr.
Jun 26 profit was ₹69.0 Cr, −12.7% year on year. On the full year, FY26 printed ₹342 Cr (+52.0%).
🚨 Why profit moved: revenue contributed +12.5% and the margin +2.0 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +70.7% vs revenue +27.1%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
FY26-Q4. revenue ₹243 Cr and profit ₹74 Cr as reported.
FY27-Q1. revenue ₹234 Cr and profit ₹69 Cr as reported.
Why-sources: our stock research file (19 July 2026) and the company’s own results for those quarters.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 247% of Aegis Vopak Terminals Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹702 Cr of operating cash against ₹342 Cr of profit. After ₹1,855 Cr of capital spending, ₹−1,153 Cr was left as free cash.
FY26: operating cash of ₹702 Cr against reported profit of ₹342 Cr, leaving free cash of ₹−1,153 Cr after ₹1,855 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 247% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 247%: the cash cycle held roughly steady between FY23 and FY26 — so conversion tracks profitability rather than the cycle.
Router verdict: the bigger cash user is investment — capital spending ran 8.8× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Aegis Vopak Terminals Ltd's cash conversion cycle runs 74 days in FY26, up from 72 days in FY23. Capital spending ran ₹4,148 Cr over the last 3 years. At FY26 sales of ₹923 Cr each day of that cycle holds about ₹2.5 Cr, so roughly ₹187 Cr sits inside the business at any moment.
Why this happened. The ammonia terminal has capacity and a long-duration offtake arrangement, while a strategic investor provides additional qualitative support. The counterparty's plant timing and reported ammonia revenue are the proof points.
FY26: debtors at 74 days (an asset-light business — no inventory to speak of) — for a full cycle of 74 days, looser than FY23's 72.
In money terms: at FY26 sales of ₹923 Cr, each day of the cycle holds about ₹2.5 Cr — so the 74-day loop keeps roughly ₹187 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹4,148 Cr over the last 3 fiscal years against ₹470 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹210 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Aegis Vopak Terminals Ltd earns a ROCE of 8% in FY26. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 37.1% net margin on 0.11× asset turns.
FY26 ROCE is 8%.
Why the return is what it is — the wiring (FY26): 37.1% net margin × 0.11× asset turns × 1.96× balance-sheet leverage ≈ 8.0% on equity. Margin is doing the heavy lifting; leverage is a meaningful part of the equation.
The quarterly return curves and the return-on-invested-capital overlay, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 98% on reported income across 8 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
Aegis Vopak Terminals Ltd carries ₹3,731 Cr of borrowings against ₹4,291 Cr of equity in FY26, a debt-to-equity of 0.87. Operating profit covers the interest bill 6×. Over 4 years borrowings went from ₹98.0 Cr to ₹3,731 Cr. Capital spending ran ₹4,148 Cr across the last 3 of those years.
FY26: borrowings of ₹3,731 Cr against equity of ₹4,291 Cr — a debt-to-equity of 0.87. Operating profit covers the interest bill 6×. Over 4 years borrowings went from ₹98.0 Cr to ₹3,731 Cr while capital spending ran ₹4,148 Cr in just the last 3 — part of the build-out is riding on borrowed money.
The total-debt and debt-to-equity series, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 98% on reported income across 8 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of Aegis Vopak Terminals Ltd moved a full percentage point over the last two years — the register is quiet. Promoters moved +0.0 points over the same window, to 86.9%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Foreign institutions: −0.5 points over 4 quarters to 5.3%; Promoters: +0.0 points over 4 quarters to 86.9%; Domestic institutions: +0.0 points over 4 quarters to 5.3%.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Aegis Vopak Terminals Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Aegis Vopak Terminals Ltd trades at 121.0× P/E, mid-range by its own standards (69th percentile). Its long-run median P/E is 112.5×, measured across 1.3 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 121.0× is mid-range by its own standards (69th percentile), against a long-run median of 112.5× measured over 1.3 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +37.9% against a +19.4% price move — earnings outran the price, pushing the multiple DOWN its own range.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
The PEG ratio and its quarterly curve, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 98% on reported income across 8 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Aegis Vopak Terminals Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 5 quarters across 1 curve, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +17.0% | +37.8% | — | — |
| Profit | +52.0% | — | — | — |
| EPS | +37.9% | — | — | — |
| Share price | +19.4% | — | — | — |
4-Factor Sector Score
55.8/100 — rank 9 of 36 in Miscellaneous · 60% evidence confidence
Aegis Vopak Terminals Ltd scores 55.8 out of 100 against the 36 companies it is compared with in Miscellaneous, ranking 9. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 21.9 + 13.2 + 8.9 + 11.8 = 55.8. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Said versus delivered
What Aegis Vopak Terminals Ltd's management promised, set against what actually arrived — 4 tracked promises on the record. Read straight from the company’s own earnings calls. A promise that slipped stays on this page after it is met.
JNPA Liquid Expansion Timeline Delayed · 14 August 2026. Management stated in both January and June 2026 that the first phase of the JNPA liquid expansion would be operational in Q1 FY27. The latest call moves commissioning to Q3 FY27, a two-quarter delay with no explanation, which affects the timing of FY27 capacity and revenue contributions.
🚨 FY27 Liquid Capacity Target Softened · 14 August 2026. In January 2026, management expected liquid capacity to reach approximately 2.5 million cubic meters or more by the end of FY27. The latest call describes a path from 1.7 million to 2.2 million by March, implying a target roughly 12% below the prior FY27-end expectation, without explaining the reduction.
Throughput Growth Target Softened · 14 August 2026. The June 2026 call indicated expected throughput growth of 30%-40% for the current year, while the latest call states a lower minimum objective of at least 25% annual volume growth. Although at least 25% is not a hard ceiling and could still allow 30%-40% growth, the latest statement is a less aggressive stated target and management did not reconcile the change.
Unexplained Reversal on South India Capacity Expansions · 9 June 2026. In the Nov 2025 call, management provided a firm completion deadline of December 2026 for the 60,000 cubic meter liquid capacity expansions at both Mangalore and Kochi. In the Jan 2026 call, they further confirmed that development at Kochi was actively underway. However, in the Jun 2026 call, management completely walked back this progress, stating that timelines would now only be provided once plans are fully finalized, effectively abandoning the previously guaranteed 2026 deadline and active construction status without explanation.
Every quote above is taken word for word from the company’s own earnings calls.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Gulshan Polyols LtdGULPOLY | 70.7/100Favorable setup87% evidence | ASLEEP | 27.5/35 Revenue 9.4% · PAT 100% · OPM change 7 pp 95% evidence | 19.2/25 ROCE 18.6% · OPM 13% 95% evidence | 13.2/20 P/E 7.4× · PEG — 50% evidence | 10.8/20 RS sector 3.7% · RS bench 7% · 1Y 8.8%5 of 12 weeks ahead 100% evidence |
| Exact sum: 27.5 + 19.2 + 13.2 + 10.8 = 70.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Sagility LtdSAGILITY | 67.6/100Favorable setup87% evidence | TURNING | 24.7/35 Revenue 29.4% · PAT 49.3% · OPM change 0 pp 100% evidence | 15.8/25 ROCE 13.4% · OPM 22% 100% evidence | 13.5/20 P/E 20.6× · PEG 1.08 65% evidence | 13.6/20 RS sector 7.2% · RS bench 1.7% · 1Y 5.3%3 of 10 weeks ahead 70% evidence |
| Exact sum: 24.7 + 15.8 + 13.5 + 13.6 = 67.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3IIRM Holdings India Ltd526530 | 64.2/100Mixed-positive evidence75% evidence | LEADER | 16.3/35 Revenue 14.9% · PAT 12.7% · OPM change 1.1 pp 95% evidence | 19.0/25 ROCE 20.4% · OPM 24.6% 76% evidence | 9.9/20 P/E 39.9× · PEG — 15% evidence | 19.0/20 RS sector 42.8% · RS bench 47.3% · 1Y 79.1%11 of 12 weeks ahead 100% evidence |
| Exact sum: 16.3 + 19 + 9.9 + 19 = 64.2 · Decision use: Price leads the evidence: RS versus the benchmark is 47.3%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 4Exhicon Events Media Solutions Ltd543895 | 63.7/100Thin evidence · provisional60% evidence | TURNING | 19.0/35 Revenue 100% · PAT 100% · OPM change 0 pp 48% evidence | 20.1/25 ROCE 29.5% · OPM 28% 76% evidence | 13.4/20 P/E 19.2× · PEG — 50% evidence | 11.2/20 RS sector 2.2% · RS bench -1.9% · 1Y -4.8%2 of 10 weeks ahead 70% evidence |
| Exact sum: 19 + 20.1 + 13.4 + 11.2 = 63.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 5Aeroflex Enterprises LtdAEROENTER | 62.8/100Mixed-positive evidence87% evidence | LEADER | 19.7/35 Revenue 27.5% · PAT 100% · OPM change -5 pp 95% evidence | 14.9/25 ROCE 12.6% · OPM 9% 95% evidence | 9.0/20 P/E 10.2× · PEG — 50% evidence | 19.2/20 RS sector 38.8% · RS bench 42.9% · 1Y 57.7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 19.7 + 14.9 + 9 + 19.2 = 62.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Global Education LtdGLOBAL | 62.5/100Mixed-positive evidence80% evidence | TURNING | 14.2/35 Revenue 28.2% · PAT 3.3% · OPM change 0.3 pp 95% evidence | 19.8/25 ROCE 29.2% · OPM 41% 95% evidence | 10.1/20 P/E 24.8× · PEG — 15% evidence | 18.4/20 RS sector 32.4% · RS bench 36.9% · 1Y 97.6%2 of 12 weeks ahead 100% evidence |
| Exact sum: 14.2 + 19.8 + 10.1 + 18.4 = 62.5 · Decision use: Price leads the evidence: RS versus the benchmark is 36.9%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 7Take Solutions LtdTAKE | 58.7/100Thin evidence · provisional57% evidence | 24.7/35 Revenue — · PAT 100% · OPM change 2932.2 pp 57% evidence | 8.5/25 ROCE 11.2% · OPM — 80% evidence | 8.5/20 P/E 3222× · PEG — 15% evidence | 17.0/20 RS sector 71.1% · RS bench 71.4% · 1Y 300.4%11 of 12 weeks ahead to 2026-05-03 70% evidence | |
| Exact sum: 24.7 + 8.5 + 8.5 + 17 = 58.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 8R K Swamy LtdRKSWAMY | 57.1/100Mixed-positive evidence65% evidence | 22.5/35 Revenue 14.3% · PAT 17.3% · OPM change 2.6 pp 95% evidence | 15.6/25 ROCE 12.3% · OPM 10.4% 95% evidence | 10.7/20 P/E 19.5× · PEG — 15% evidence | 8.3/20 RS sector — · RS bench -16.7% · 1Y —4 of 5 weeks ahead to 2026-08-16 25% evidence | |
| Exact sum: 22.5 + 15.6 + 10.7 + 8.3 = 57.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Aegis Vopak Terminals Ltdthis pageAEGISVOPAK | 55.8/100Mixed-positive evidence60% evidence | BREAKING OUT | 21.9/35 Revenue 25.9% · PAT 40.9% · OPM change 2 pp 95% evidence | 13.2/25 ROCE 7.6% · OPM 77% 76% evidence | 8.9/20 P/E 121× · PEG — 15% evidence | 11.8/20 RS sector — · RS bench 25.5% · 1Y 24.5%10 of 10 weeks ahead 25% evidence |
| Exact sum: 21.9 + 13.2 + 8.9 + 11.8 = 55.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Parin Enterprises LtdPARIN | 52.2/100Mixed-positive evidence63% evidence | FADING | 19.4/35 Revenue 100% · PAT 100% · OPM change -3 pp 48% evidence | 11.6/25 ROCE 10.8% · OPM 9% 95% evidence | 9.1/20 P/E 117× · PEG — 15% evidence | 12.1/20 RS sector 5.1% · RS bench 8.7% · 1Y 46.8%8 of 12 weeks ahead 100% evidence |
| Exact sum: 19.4 + 11.6 + 9.1 + 12.1 = 52.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Eveready Industries India LtdEVEREADY | 50.9/100Mixed-positive evidence94% evidence | TURNING | 18.9/35 Revenue 8.7% · PAT 100% · OPM change 1 pp 100% evidence | 13.6/25 ROCE 17.2% · OPM 15% 100% evidence | 9.0/20 P/E 16.6× · PEG 2.1 100% evidence | 9.4/20 RS sector -9.5% · RS bench 8.6% · 1Y -22.3%6 of 10 weeks ahead 70% evidence |
| Exact sum: 18.9 + 13.6 + 9 + 9.4 = 50.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12GMR Airports LtdGMRAIRPORT | 50.8/100Mixed-positive evidence74% evidence | ASLEEP | 22.7/35 Revenue 38.8% · PAT 100% · OPM change 1 pp 74% evidence | 11.3/25 ROCE 11.6% · OPM 37% 100% evidence | 8.7/20 P/E 184× · PEG — 15% evidence | 8.1/20 RS sector -2.8% · RS bench 0.5% · 1Y 14%6 of 12 weeks ahead 100% evidence |
| Exact sum: 22.7 + 11.3 + 8.7 + 8.1 = 50.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Anzen India Energy Yield Plus TrustANZEN | 50.3/100Mixed-positive evidence60% evidence | TURNING | 20.7/35 Revenue 100% · PAT 100% · OPM change -9 pp 95% evidence | 9.1/25 ROCE 3.3% · OPM 80% 76% evidence | 9.3/20 P/E 99.7× · PEG — 15% evidence | 11.2/20 RS sector — · RS bench 7.3% · 1Y 8.7%1 of 10 weeks ahead 25% evidence |
| Exact sum: 20.7 + 9.1 + 9.3 + 11.2 = 50.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Jai Corp LtdJAICORPLTD | 48.3/100Mixed-negative evidence74% evidence | BASING | 19.6/35 Revenue 2.7% · PAT -40.4% · OPM change 9 pp 95% evidence | 11.4/25 ROCE 11.8% · OPM 15% 95% evidence | 10.9/20 P/E 17.8× · PEG — 15% evidence | 6.4/20 RS sector -8.2% · RS bench -19.2% · 1Y -40.2%1 of 10 weeks ahead 70% evidence |
| Exact sum: 19.6 + 11.4 + 10.9 + 6.4 = 48.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Inox Green Energy Services LtdINOXGREEN | 48.0/100Mixed-negative evidence75% evidence | ASLEEP | 22.2/35 Revenue 16.5% · PAT 100% · OPM change -13.2 pp 95% evidence | 9.1/25 ROCE 8.4% · OPM -2.2% 76% evidence | 9.7/20 P/E 58.4× · PEG — 15% evidence | 7.0/20 RS sector -6% · RS bench -2.9% · 1Y 19.3%5 of 12 weeks ahead 100% evidence |
| Exact sum: 22.2 + 9.1 + 9.7 + 7 = 48 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16TCC Concept LtdTCC | 47.5/100Mixed-negative evidence81% evidence | BASING | 16.6/35 Revenue 100% · PAT 51.1% · OPM change -45 pp 95% evidence | 11.8/25 ROCE 5.7% · OPM 36% 95% evidence | 14.1/20 P/E 20× · PEG — 50% evidence | 5.0/20 RS sector -17.6% · RS bench -31.9% · 1Y -89.7%0 of 11 weeks ahead 70% evidence |
| Exact sum: 16.6 + 11.8 + 14.1 + 5 = 47.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Prozone Realty LtdPROZONER | 46.4/100Mixed-negative evidence80% evidence | TURNING | 17.0/35 Revenue -9.9% · PAT 100% · OPM change 8.2 pp 95% evidence | 6.4/25 ROCE -1% · OPM -35.6% 95% evidence | 9.6/20 P/E 62.1× · PEG — 15% evidence | 13.4/20 RS sector -0.3% · RS bench 3.1% · 1Y 21.7%1 of 12 weeks ahead 100% evidence |
| Exact sum: 17 + 6.4 + 9.6 + 13.4 = 46.4 · Decision use: Price leads the evidence: RS versus the benchmark is 3.1%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 18Aqylon Nexus LtdAQYLON | 45.9/100Mixed-negative evidence72% evidence | BASING | 18.5/35 Revenue 100% · PAT 100% · OPM change 2358 pp 71% evidence | 18.8/25 ROCE 131% · OPM 58% 95% evidence | 8.6/20 P/E 759× · PEG — 15% evidence | 0.0/20 RS sector -76.3% · RS bench -75.3% · 1Y -79.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.5 + 18.8 + 8.6 + 0 = 45.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Jindal Photo LtdJINDALPHOT | 43.3/100Mixed-negative evidence77% evidence | ASLEEP | 20.4/35 Revenue 100% · PAT -80% · OPM change 15 pp 95% evidence | 10.1/25 ROCE -1.4% · OPM 98% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 2.8/20 RS sector -19.1% · RS bench -16.2% · 1Y -14.4%1 of 12 weeks ahead 100% evidence |
| Exact sum: 20.4 + 10.1 + 10 + 2.8 = 43.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20Shipping Corporation of India Land & Assets LtdSCILAL | 42.8/100Mixed-negative evidence80% evidence | BASING | 24.2/35 Revenue 23.8% · PAT 100% · OPM change 13 pp 95% evidence | 5.0/25 ROCE 1.3% · OPM -14% 95% evidence | 9.5/20 P/E 62.3× · PEG — 15% evidence | 4.1/20 RS sector -17.6% · RS bench -14.8% · 1Y -26.8%2 of 12 weeks ahead 100% evidence |
| Exact sum: 24.2 + 5 + 9.5 + 4.1 = 42.8 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -17.6% and the one-year return is -26.8%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 21TruAlt Bioenergy LtdTRUALT | 40.3/100Mixed-negative evidence63% evidence | ASLEEP | 10.7/35 Revenue 1.8% · PAT -8.1% · OPM change 7 pp 100% evidence | 9.3/25 ROCE 10.4% · OPM 21% 100% evidence | 10.3/20 P/E 22.8× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y -21.6%2 of 12 weeks ahead 0% evidence |
| Exact sum: 10.7 + 9.3 + 10.3 + 10 = 40.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22GKW LtdGKWLIMITED | 39.2/100Mixed-negative evidence71% evidence | ASLEEP | 10.9/35 Revenue -13.5% · PAT 0% · OPM change -2 pp 95% evidence | 9.2/25 ROCE 0.5% · OPM 84% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 9.1/20 RS sector -0.9% · RS bench -4.5% · 1Y -9.4%2 of 10 weeks ahead 70% evidence |
| Exact sum: 10.9 + 9.2 + 10 + 9.1 = 39.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23Unitech LtdUNITECH | 36.8/100Mixed-negative evidence69% evidence | BASING | 18.0/35 Revenue 45.3% · PAT -10% · OPM change 15 pp 71% evidence | 3.5/25 ROCE 0.1% · OPM 6% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 5.3/20 RS sector -22.3% · RS bench -19.7% · 1Y -39.9%2 of 12 weeks ahead 100% evidence |
| Exact sum: 18 + 3.5 + 10 + 5.3 = 36.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24Kaveri Seed Company LtdKSCL | 35.9/100Mixed-negative evidence94% evidence | BASING | 11.3/35 Revenue 1.4% · PAT -21.7% · OPM change 1 pp 100% evidence | 14.4/25 ROCE 18.8% · OPM 40% 100% evidence | 4.7/20 P/E 14.8× · PEG 3.12 100% evidence | 5.5/20 RS sector -17.2% · RS bench -19.8% · 1Y -40%1 of 11 weeks ahead 70% evidence |
| Exact sum: 11.3 + 14.4 + 4.7 + 5.5 = 35.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25Delta Corp LtdDELTACORP | 35.4/100Mixed-negative evidence81% evidence | BASING | 9.7/35 Revenue -9.3% · PAT -80% · OPM change -3 pp 95% evidence | 8.6/25 ROCE 5.1% · OPM 18% 95% evidence | 12.0/20 P/E 9.4× · PEG — 50% evidence | 5.1/20 RS sector -18.1% · RS bench -18.3% · 1Y -36.2%1 of 10 weeks ahead 70% evidence |
| Exact sum: 9.7 + 8.6 + 12 + 5.1 = 35.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 26Stanley Lifestyles LtdSTANLEY | 30.0/100Adverse evidence74% evidence | BASING | 6.6/35 Revenue -5.6% · PAT -80% · OPM change -3.4 pp 95% evidence | 10.8/25 ROCE 6.4% · OPM 17.3% 95% evidence | 9.2/20 P/E 112× · PEG — 15% evidence | 3.4/20 RS sector -43.7% · RS bench -25.2% · 1Y -54.7%3 of 10 weeks ahead 70% evidence |
| Exact sum: 6.6 + 10.8 + 9.2 + 3.4 = 30 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 27Embassy Developments LtdEMBDL | 26.2/100Adverse evidence64% evidence | BASING | 5.9/35 Revenue -46.6% · PAT -80% · OPM change -58.4 pp 71% evidence | 3.4/25 ROCE -2.4% · OPM -60% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 6.9/20 RS sector -18.4% · RS bench -15.8% · 1Y -42.9%6 of 12 weeks ahead 100% evidence |
| Exact sum: 5.9 + 3.4 + 10 + 6.9 = 26.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 28RattanIndia Enterprises LtdRTNINDIA | 17.5/100Adverse evidence74% evidence | ASLEEP | 2.7/35 Revenue 2.1% · PAT -80% · OPM change -23.9 pp 100% evidence | 1.0/25 ROCE -4.8% · OPM 2.1% 100% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.8/20 RS sector -32.1% · RS bench -24.4% · 1Y -55.3%1 of 10 weeks ahead 70% evidence |
| Exact sum: 2.7 + 1 + 10 + 3.8 = 17.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 29Central Mine Planning & Design Institute LtdCMPDI | 63.2/100Thin evidence · provisional40% evidence | ASLEEP | 22.4/35 Revenue — · PAT — · OPM change 8 pp 34% evidence | 20.6/25 ROCE 38.1% · OPM 30% 100% evidence | 10.2/20 P/E 23.5× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —4 of 9 weeks ahead 0% evidence |
| Exact sum: 22.4 + 20.6 + 10.2 + 10 = 63.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 30FlySBS Aviation LtdFLYSBS | 57.7/100Thin evidence · provisional41% evidence | BREAKING OUT | 15.4/35 Revenue — · PAT — · OPM change -8 pp 26% evidence | 19.4/25 ROCE 32.5% · OPM 21% 95% evidence | 10.6/20 P/E 20× · PEG — 15% evidence | 12.3/20 RS sector — · RS bench 43.9% · 1Y 14.1%6 of 10 weeks ahead 25% evidence |
| Exact sum: 15.4 + 19.4 + 10.6 + 12.3 = 57.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 31Qualitek Labs Ltd544091 | 54.3/100Thin evidence · provisional29% evidence | BREAKING OUT | 17.3/35 Revenue — · PAT — · OPM change -3 pp 7% evidence | 15.1/25 ROCE 11.9% · OPM 26% 76% evidence | 9.8/20 P/E 44.2× · PEG — 15% evidence | 12.1/20 RS sector — · RS bench 42.7% · 1Y —4 of 6 weeks ahead 25% evidence |
| Exact sum: 17.3 + 15.1 + 9.8 + 12.1 = 54.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 32Shree Vasu Logistics LtdSVLL | 52.6/100Thin evidence · provisional50% evidence | BREAKING OUT | 18.3/35 Revenue — · PAT — · OPM change 0.8 pp 26% evidence | 16.0/25 ROCE 12.9% · OPM 25.8% 95% evidence | 8.8/20 P/E 126× · PEG — 15% evidence | 9.5/20 RS sector -16.1% · RS bench 17.5% · 1Y 2.2%10 of 10 weeks ahead 70% evidence |
| Exact sum: 18.3 + 16 + 8.8 + 9.5 = 52.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 33Indiqube Spaces LtdINDIQUBE | 49.7/100Thin evidence · provisional49% evidence | BREAKING OUT | 18.9/35 Revenue 38.9% · PAT 30.4% · OPM change 0 pp 71% evidence | 9.3/25 ROCE 6.4% · OPM 61% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 11.5/20 RS sector — · RS bench 10.4% · 1Y -11.8%5 of 10 weeks ahead 25% evidence |
| Exact sum: 18.9 + 9.3 + 10 + 11.5 = 49.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 34Maagh Advertising & Marketing Services Ltd543624 | 49.5/100Thin evidence · provisional35% evidence | 18.4/35 Revenue — · PAT — · OPM change 275.6 pp 32% evidence | 9.1/25 ROCE -0.4% · OPM 55.6% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 12.0/20 RS sector — · RS bench 37% · 1Y —7 of 9 weeks ahead to 2025-03-19 25% evidence | |
| Exact sum: 18.4 + 9.1 + 10 + 12 = 49.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 35Tandhan Industries Ltd512062 | 46.3/100Thin evidence · provisional33% evidence | BREAKING OUT | 20.2/35 Revenue — · PAT 100% · OPM change — 33% evidence | 6.7/25 ROCE -0.3% · OPM 15.8% 76% evidence | 9.4/20 P/E 71.2× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —10 of 10 weeks ahead 0% evidence |
| Exact sum: 20.2 + 6.7 + 9.4 + 10 = 46.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 36Shree Rama Newsprint LtdRAMANEWS | 45.4/100Thin evidence · provisional46% evidence | 14.1/35 Revenue -20% · PAT 69.8% · OPM change -8 pp 40% evidence | 6.1/25 ROCE 1.9% · OPM 8% 71% evidence | 10.0/20 P/E — · PEG — 0% evidence | 15.2/20 RS sector 9.7% · RS bench 10.5% · 1Y 21.7%11 of 12 weeks ahead to 2026-04-19 70% evidence | |
| Exact sum: 14.1 + 6.1 + 10 + 15.2 = 45.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Aegis Vopak Terminals Ltd's share price today?
Aegis Vopak Terminals Ltd trades at ₹295, +19.4% over the past year. The company is valued at ₹32,697 Cr. The stock sits at the very top of its 52-week range (₹172–₹295), +20.2% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 9 weeks in. — as of 11 September 2026.
What were Aegis Vopak Terminals Ltd's latest quarterly results?
Aegis Vopak Terminals Ltd reported revenue of ₹234 Cr and net profit of ₹69.0 Cr for the Jun 26 quarter. Revenue rose 12.5% and profit fell 12.7% year on year. Earnings per share were ₹0.60. The operating margin was 77.0%, 2.0 pp higher than a year earlier. — as of 11 September 2026.
What is Aegis Vopak Terminals Ltd's revenue?
Aegis Vopak Terminals Ltd reported revenue of ₹234 Cr in the Jun 26 quarter, +12.5% year on year. For the full FY26 fiscal year, revenue was ₹923 Cr (+17.0%). — as of 11 September 2026.
What is Aegis Vopak Terminals Ltd's profit?
Aegis Vopak Terminals Ltd earned ₹69.0 Cr of net profit in the Jun 26 quarter, −12.7% year on year. Full-year FY26 profit was ₹342 Cr. The operating margin ran 77.0% in the latest quarter. — as of 11 September 2026.
What is Aegis Vopak Terminals Ltd's market cap?
Aegis Vopak Terminals Ltd's market capitalisation is ₹32,697 Cr at a share price of ₹295. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is Aegis Vopak Terminals Ltd's P/E ratio?
Aegis Vopak Terminals Ltd trades at a P/E of 121.0×, at the 69th percentile of its own 1-year range, against a long-run median of 112.5×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does Aegis Vopak Terminals Ltd pay a dividend?
Yes — Aegis Vopak Terminals Ltd's dividend payout was 71% of profit in FY26, and it recorded a payout in 2 of its last 5 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.
Is Aegis Vopak Terminals Ltd overvalued?
On its own history, Aegis Vopak Terminals Ltd looks expensive: its P/E of 121.0× sits at the 69th percentile of its 1-year range (long-run median 112.5×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.
Is Aegis Vopak Terminals Ltd growing?
Yes — Aegis Vopak Terminals Ltd is growing: latest-quarter revenue +12.5% year on year, profit −12.7%, and the margin +2.0 pp at 77.0%. The earnings engine currently reads: improving — as of 11 September 2026.
How is Aegis Vopak Terminals Ltd performing?
Aegis Vopak Terminals Ltd is in a confirmed uptrend, 9 weeks in. Its latest quarter's revenue rose 12.5% and profit fell 12.7% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 17 weeks. This describes what the data did, not a rating. — as of 11 September 2026.
Is Aegis Vopak Terminals Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 9 of stage 2), trading +20.2% versus its 200-day average and at the very top of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is Aegis Vopak Terminals Ltd beating the market?
On recent form, yes — Aegis Vopak Terminals Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 17 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 1.3 years the stock moved +15% against the NIFTY 500's −2% — ahead of the index over the full window. — as of 11 September 2026.
Will Aegis Vopak Terminals Ltd's share price go up?
This page publishes no price forecast for Aegis Vopak Terminals Ltd. What it measures instead: the share price is ₹295, the price is in a confirmed uptrend 9 weeks in. Its P/E of 121.0× sits at the 69th percentile of its own 1-year range. — as of 11 September 2026.
Who owns Aegis Vopak Terminals Ltd?
Promoters hold 86.9% of Aegis Vopak Terminals Ltd, foreign institutions 5.3%, domestic institutions 5.3% and the public 2.4% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 11 September 2026.
Does Aegis Vopak Terminals Ltd have too much debt?
It is moderate — Aegis Vopak Terminals Ltd's debt-to-equity is 0.87, and operating profit covers the interest bill 6×. FY26 borrowings were ₹3,731 Cr against equity of ₹4,291 Cr. Read the returns on this page with that leverage in mind — as of 11 September 2026.
What is Aegis Vopak Terminals Ltd's capex?
Aegis Vopak Terminals Ltd spent ₹4,148 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹1,855 Cr, with ₹210 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.
What is Aegis Vopak Terminals Ltd's cash flow?
Aegis Vopak Terminals Ltd generated ₹702 Cr of operating cash flow in FY26 and ₹−1,153 Cr of free cash flow after ₹1,855 Cr of capital spending. Reported profit that year was ₹342 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 11 September 2026.
Is Aegis Vopak Terminals Ltd's profit real cash?
Yes — over the last 3 fiscal years, 247% of Aegis Vopak Terminals Ltd's reported profit arrived as operating cash. Though the latest year ran at 205% — the trend is the thing to watch. In FY26, operating cash was ₹702 Cr against reported profit of ₹342 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 11 September 2026.
Where is Aegis Vopak Terminals Ltd in its business cycle?
Aegis Vopak Terminals Ltd's FY26 operating margin was 74.0%, against a 4-year band of 65.0%–74.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 77.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What could break the Aegis Vopak Terminals Ltd story?
Biggest watch item: the P/E sits at the 69th percentile of its own range — the multiple has already done part of the work. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is Aegis Vopak Terminals Ltd a stock worth studying right now?
This is not investment advice. The machine read: Aegis Vopak Terminals Ltd's earnings have outrun its stock. EPS grew +37.9% in a year against a +19.4% price move. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!